LABORATORY RESEARCH Signaling Pathway for RKIP and Let-7 Regulates and Predicts Metastatic Breast Cancer Here, scientists demonstrate an integrated approach combining statistical analysis of breast tumor gene expression data and experimental validation to extend the signaling pathway for Raf kinase inhibitory protein (RKIP). [EMBO J] Abstract An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer Scientists capitalized on publicly available microarray datasets comprising 674 breast cancer cases to systematically investigate how expression of genes related to iron metabolism is linked to breast cancer prognosis. [Cancer Res] Abstract Pivotal Role of Reduced Let-7g Expression in Breast Cancer Invasion and Metastasis Investigators identify let-7g as a unique member of the let-7 miRNA family which can serve as a prognostic biomarker in breast cancer and also propose a paradigm utilized by specific signaling molecules via let-7g to cooperatively promote breast cancer invasion and metastasis. [Cancer Res] Abstract Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer Because glucocorticoid receptor signaling initiates anti-apoptotic pathways in estrogen-negative (ER−) breast cancer cells, researchers hypothesized that activation of these pathways might be associated with poor prognosis in ER− disease. [Cancer Res] Abstract Introduction of Simian Virus 40 Early Region and hTERT into Mammospheres Generates Breast Cancer Cells with Stem Cell Properties In this study, investigators have exploited the ‘mammosphere’ system that selects for primitive mammary stem/progenitor cells to explore their potential and requirements for transformation. [Oncogene] Abstract Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells Using microarray analysis, scientists observed that metastatic breast tumors resistant to tamoxifen therapy had elevated levels of Dicer. [Clin Cancer Res] Abstract Involvement of Akt and mTOR in Chemotherapeutic- and Hormonal-Based Drug Resistance and Response to Radiation in Breast Cancer Cells In the following studies researchers have examined the effects of activation of the Ras/PI3K/PTEN/Akt/mTOR cascade in the response of MCF-7 breast cancer cells to chemotherapeutic- and hormonal-based drugs and radiation. [Cell Cycle] Abstract ADAM12 Produced by Tumor Cells Rather Than Stromal Cells Accelerates Breast Tumor Progression In the present study, investigators found that ADAM12 deficiency reduces breast tumor progression in the mouse model of breast cancer. [Mol Cancer Res] Abstract CLINICAL RESEARCH Risk of Breast Cancer in Women with a CHEK2 Mutation with and without a Family History of Breast Cancer The purpose of this study is to estimate the risk of breast cancer in a woman who has a CHEK2 mutation depending on her family history of breast cancer. [J Clin Oncol] Abstract | Press Release Mortality Rates Among Early-Stage Hormone Receptor–Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark Researchers aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy. [J Natl Cancer Inst] Abstract | Press Release Randomized Phase II Trial of Letrozole Plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer Investigators compared the outcomes of patients with breast cancer treated with letrozole with or without AS1402. [Clin Cancer Res] Abstract |